Gut Microbiota for Health World Summit - Washington 2021

Program
2022 GMFH Summit

Friday, March 11

1 pm – Satellite symposium

Details to be announced

3 pm – Registration


Saturday, March 12

7 am – Breakfast and Registration

7:45 am – Product Theater

8:30 am – Welcome
Gail A. Hecht, MD, MS, Loyola University Medical Center

8:45 am – Keynote Lecture

9:15 am – PLENARY SESSION 1: Impact of Diet on the Human Gut Microbiome

Fermented food as a modulator of the gut microbiome
Effect of immigration on the gut microbiome
Effect of cooking on the microbiome

10:45 am – Morning Break

11:15 am – PLENARY SESSION 2: Gut Microbiota in Precision Medicine

Precision nutrition and the human gut microbiome
Brain-gut axis in functional gastrointestinal disorders
Circadian rhythm and gut microbiome signatures in type 2 diabetes

12:45 pm – Lunch

1:15 pm – Product Theater

2 pm – Breakout Sessions (two concurrent sessions)

Workshop 1: Defining a “healthy” microbiome
Workshop 2: Circadian control of microbiota functionality

3:15 pm – Afternoon Break

3:45 pm – Breakout Sessions (two concurrent sessions)

Workshop 3: Designing microbiome trials – unique considerations
Workshop 4: Modulating microbial pathways as a therapeutic strategy

5 pm – Networking Reception

7 pm – End of Day 1


Sunday, March 13

7 am – Breakfast and Registration

7:45 am – Sponsor Product Theater

8:30 am – PLENARY SESSION 3: Update on Microbiota-based Therapies

Status of commercial stool-based therapies
Defined microbial communities
Microbiota as a modulator of cancer therapy

10 am – Morning Break

10:30 am – PLENARY SESSION 4: Probiotics – Outlook for the Future

Rational selection of microbes as probiotics
Genetically engineered bacteria and synthetic bacteria as probiotics
Microbiota-derived small molecules as probiotics

12 pm – Closing Lecture
COVID-19, the GI Tract, and the Microbiome: What Do We Know Today?

12:30 pm – Closing Remarks

12:35 pm – End of Program


CME information

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Gastroenterological Association (AGA) Institute and the European Society of Neurogastroenterology & Motility (ESNM).

The AGA Institute is accredited by the ACCME to provide continuing medical education for physicians. The AGA Institute designates this live activity for a maximum of 9.5 AMA PRA Category 1 Credits™.

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In accordance with the ACCME’s Standards for Commercial Support of Continuing Medical Education, all faculty and planning partners must disclose any financial relationship(s) or other relationship(s) held within the past 12 months. The AGA Institute implements a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.